{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:20:30Z","timestamp":1791951630317,"version":"4.3.4"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Polycystic ovary syndrome is one of the most common endocrine disorders among women of childbearing age. The relationship between polycystic ovary syndrome and chronic kidney disease remains unclear and controversial. In this study, we investigated the causal role of polycystic ovary syndrome in the development of chronic kidney disease using the two-sample Mendelian randomization method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Public shared summary-level data was acquired from European-ancestry genome wide association studies. We finally obtained 12 single nucleotide polymorphisms as instrumental variables, which were associated with polycystic ovary syndrome in European at genome-wide significance (P &amp;lt; 5 \u00d7 10<jats:sup>\u22128<\/jats:sup>). Inverse-variance weighted method was employed in the Mendelian randomization analysis and multiple sensitivity analyses were implemented. Outcome data were obtained from the Open GWAS database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A positive causal association was observed between polycystic ovary syndrome and chronic kidney disease (odds ratio [OR]=1.180, 95% confidence interval [CI]: 1.038-1.342; P=0.010). Further analyses clarified that causal relationship exist between polycystic ovary syndrome and some serological indicators of chronic kidney disease (fibroblast growth factor 23: OR= 1.205, 95% CI: 1.031-1.409, P=0.019; creatinine: OR= 1.012, 95% CI: 1.001-1.023, P=0.035; cystatin C: OR= 1.024, 95% CI: 1.006-1.042, P=0.009). However, there was no causal association of polycystic ovary syndrome with other factors in the data sources we employed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our results indicate an important role of polycystic ovary syndrome in the development of chronic kidney disease. This study suggests that regular follow-up of renal function in patients with polycystic ovary syndrome is necessary for the early treatment of chronic kidney disease. <\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1120119","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T05:44:58Z","timestamp":1678859098000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Causal relationship between polycystic ovary syndrome and chronic kidney disease: A Mendelian randomization study"],"prefix":"10.3389","volume":"14","author":[{"given":"Yufei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod (Oxford England)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-9-39","article-title":"The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian pcos prevalence study","volume":"9","author":"Tehrani","year":"2011","journal-title":"Reprod Biol Endocrinol RB&E"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1038\/ncomms9464","article-title":"Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome","volume":"6","author":"Day","year":"2015","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1038\/ncomms8502","article-title":"Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations","volume":"6","author":"Hayes","year":"2015","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2384","article-title":"Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome","volume":"44","author":"Shi","year":"2012","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12882-015-0189-z","article-title":"The burden of comorbidity in people with chronic kidney disease stage 3: A cohort study","volume":"16","author":"Fraser","year":"2015","journal-title":"BMC Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2016050562","article-title":"Global cardiovascular and renal outcomes of reduced gfr","volume":"28","author":"Thomas","year":"2017","journal-title":"J Am Soc Nephrol JASN"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the global burden of disease study 2017","volume":"395","year":"2020","journal-title":"Lancet (London England)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-018-2047-y","article-title":"The effect of chronic kidney disease on lipid metabolism","volume":"51","author":"Dincer","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/s0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"Lancet (London England)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.12.120","article-title":"Predictors of urinary albumin excretion in women with polycystic ovary syndrome","volume":"93","author":"Duleba","year":"2010","journal-title":"Fertil Steril"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.22074\/ijfs.2015.4238","article-title":"Association of glomerular filtration rate with inflammation in polycystic ovary syndrome","volume":"9","author":"Gozukara","year":"2015","journal-title":"Int J Fertil Steril"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.01.048","article-title":"Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome","volume":"220","author":"Moulana","year":"2019","journal-title":"Life Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.3390\/ijms22052576","article-title":"Impact of sglt-2 inhibition on cardiometabolic abnormalities in a rat model of polycystic ovary syndrome","volume":"22","author":"Pruett","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"Jama"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: Genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-Scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PloS Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"08","DOI":"10.1101\/2020.08.10.244293","article-title":"The mrc ieu opengwas data infrastructure","volume":"2020","author":"Elsworth","year":"2020","journal-title":"bioRxiv"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (Strobe) statement: Guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg (London England)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: A review","volume":"322","author":"Chen","year":"2019","journal-title":"Jama"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-020518-114605","article-title":"Biomarkers of acute and chronic kidney disease","volume":"81","author":"Zhang","year":"2019","journal-title":"Annu Rev Physiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent developments in mendelian randomization studies","volume":"4","author":"Zheng","year":"2017","journal-title":"Curr Epidemiol Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: Effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1038\/s41467-018-06467-9","article-title":"A mendelian randomization study of the effects of blood lipids on breast cancer risk","volume":"9","author":"Nowak","year":"2018","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e13461","DOI":"10.14814\/phy2.13461","article-title":"Consequences of advanced aging on renal function in chronic hyperandrogenemic female rat model: Implications for aging women with polycystic ovary syndrome","volume":"5","author":"Patil","year":"2017","journal-title":"Physiol Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14284","article-title":"The risk of chronic kidney disease among women with polycystic ovary syndrome: A long-term population-based cohort study","volume":"93","author":"Behboudi-Gandevani","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on pcos: Consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14219","article-title":"Serum testosterone acts as a prognostic indicator in polycystic ovary syndrome-associated kidney injury","volume":"7","author":"Song","year":"2019","journal-title":"Physiol Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2460","article-title":"Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: Implications of the new chronic kidney disease epidemiology collaboration creatinine equation for estimating glomerular filtration rate","volume":"24","author":"Butt","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin c-based equations to estimate gfr without race","volume":"385","author":"Inker","year":"2021","journal-title":"New Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29290","article-title":"Plasma cystatin c is a predictor of renal dysfunction, acute-on-Chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis","volume":"66","author":"Markwardt","year":"2017","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2022.114234","article-title":"Microneedle patches integrated with lateral flow cassettes for blood-free chronic kidney disease point-of-Care testing during a pandemic","volume":"208","author":"Chen","year":"2022","journal-title":"Biosens Bioelectron"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4274\/tjod.galenos.2022.29498","article-title":"The role of inflammation, oxidation and cystatin-c in the pathophysiology of polycystic ovary syndrome","volume":"19","author":"\u00d6zdemir Ba\u015fer","year":"2022","journal-title":"Turk J Obstet Gynecol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ndt\/gfy126","article-title":"Klotho and endocrine fibroblast growth factors: Markers of chronic kidney disease progression and cardiovascular complications","volume":"34","author":"Kuro","year":"2019","journal-title":"Nephrology dialysis Transplant Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc"},{"key":"B42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41413-021-00154-0","article-title":"Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease","volume":"9","author":"Courbon","year":"2021","journal-title":"Bone Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/jci57582","article-title":"Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice","volume":"121","author":"Fujiu","year":"2011","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1120119\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T05:45:05Z","timestamp":1678859105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1120119\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":43,"alternative-id":["10.3389\/fendo.2023.1120119"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1120119","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"article-number":"1120119"}}